EP3538898 - PROTHROMBIN TIME REAGENT COMPRISING AN IRON CHELATOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.10.2020 Database last updated on 15.07.2024 | |
Former | The patent has been granted Status updated on 01.11.2019 | ||
Former | Grant of patent is intended Status updated on 10.09.2019 | ||
Former | Request for examination was made Status updated on 16.08.2019 | ||
Former | The international publication has been made Status updated on 07.06.2019 | ||
Former | unknown Status updated on 21.12.2018 | Most recent event Tooltip | 08.09.2023 | Lapse of the patent in a contracting state New state(s): SI | published on 11.10.2023 [2023/41] | Applicant(s) | For all designated states Siemens Healthcare Diagnostics Products GmbH Emil-von-Behring-Strasse 76 35041 Marburg / DE | [2019/38] | Inventor(s) | 01 /
PILGRIM, Sabine Georg-Elser-Straße 4 35037 Marburg / DE | 02 /
WISSEL, Thomas Am Kornacker 11 35094 Lahntal / DE | 03 /
ZANDER, Norbert Alter Kirchhainer Weg 27 35039 Marburg / DE | [2019/38] | Application number, filing date | 18815546.9 | 27.11.2018 | [2019/38] | WO2018EP82632 | Priority number, date | EP20170204000 | 28.11.2017 Original published format: EP 17204000 | [2019/38] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2019105907 | Date: | 06.06.2019 | Language: | DE | [2019/23] | Type: | A1 Application with search report | No.: | EP3538898 | Date: | 18.09.2019 | Language: | DE | The application published by WIPO in one of the EPO official languages on 06.06.2019 takes the place of the publication of the European patent application. | [2019/38] | Type: | B1 Patent specification | No.: | EP3538898 | Date: | 04.12.2019 | Language: | DE | [2019/49] | Search report(s) | International search report - published on: | EP | 06.06.2019 | Classification | IPC: | G01N33/86 | [2019/38] | CPC: |
G01N33/86 (EP,US);
G01N2333/7454 (EP,US);
G01N2800/224 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/38] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | PROTHROMBINZEIT-REAGENZ ENTHALTEND EINEN EISENCHELATOR | [2019/38] | English: | PROTHROMBIN TIME REAGENT COMPRISING AN IRON CHELATOR | [2019/38] | French: | RÉACTIF POUR LE TEMPS DE PROTHROMBINE CONTENANT UN CHÉLATEUR DU FER | [2019/38] | Entry into regional phase | 12.06.2019 | National basic fee paid | 12.06.2019 | Designation fee(s) paid | 12.06.2019 | Examination fee paid | Examination procedure | 12.06.2019 | Examination requested [2019/38] | 12.06.2019 | Date on which the examining division has become responsible | 11.09.2019 | Communication of intention to grant the patent | 22.10.2019 | Receipt of the translation of the claim(s) | 23.10.2019 | Fee for grant paid | 23.10.2019 | Fee for publishing/printing paid | Opposition(s) | 07.09.2020 | No opposition filed within time limit [2020/46] |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 27.11.2018 | AL | 04.12.2019 | CY | 04.12.2019 | CZ | 04.12.2019 | DK | 04.12.2019 | EE | 04.12.2019 | FI | 04.12.2019 | HR | 04.12.2019 | LT | 04.12.2019 | LV | 04.12.2019 | MC | 04.12.2019 | MK | 04.12.2019 | MT | 04.12.2019 | PL | 04.12.2019 | RO | 04.12.2019 | RS | 04.12.2019 | SI | 04.12.2019 | SK | 04.12.2019 | SM | 04.12.2019 | TR | 04.12.2019 | BG | 04.03.2020 | NO | 04.03.2020 | GR | 05.03.2020 | IS | 04.04.2020 | PT | 29.04.2020 | [2023/41] |
Former [2022/33] | HU | 27.11.2018 | |
AL | 04.12.2019 | ||
CY | 04.12.2019 | ||
CZ | 04.12.2019 | ||
DK | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
MC | 04.12.2019 | ||
MK | 04.12.2019 | ||
MT | 04.12.2019 | ||
PL | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
SK | 04.12.2019 | ||
SM | 04.12.2019 | ||
TR | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
IS | 04.04.2020 | ||
PT | 29.04.2020 | ||
Former [2022/27] | HU | 27.11.2018 | |
AL | 04.12.2019 | ||
CY | 04.12.2019 | ||
CZ | 04.12.2019 | ||
DK | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
MC | 04.12.2019 | ||
MT | 04.12.2019 | ||
PL | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
SK | 04.12.2019 | ||
SM | 04.12.2019 | ||
TR | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
IS | 04.04.2020 | ||
PT | 29.04.2020 | ||
Former [2021/31] | AL | 04.12.2019 | |
CZ | 04.12.2019 | ||
DK | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
MC | 04.12.2019 | ||
PL | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
SK | 04.12.2019 | ||
SM | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
IS | 04.04.2020 | ||
PT | 29.04.2020 | ||
Former [2020/51] | AL | 04.12.2019 | |
CZ | 04.12.2019 | ||
DK | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
PL | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
SK | 04.12.2019 | ||
SM | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
IS | 04.04.2020 | ||
PT | 29.04.2020 | ||
Former [2020/47] | AL | 04.12.2019 | |
CZ | 04.12.2019 | ||
DK | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
SK | 04.12.2019 | ||
SM | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
IS | 04.04.2020 | ||
PT | 29.04.2020 | ||
Former [2020/40] | AL | 04.12.2019 | |
CZ | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
SK | 04.12.2019 | ||
SM | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
IS | 04.04.2020 | ||
PT | 29.04.2020 | ||
Former [2020/37] | AL | 04.12.2019 | |
CZ | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
SK | 04.12.2019 | ||
SM | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
PT | 29.04.2020 | ||
Former [2020/36] | AL | 04.12.2019 | |
CZ | 04.12.2019 | ||
EE | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
PT | 29.04.2020 | ||
Former [2020/35] | AL | 04.12.2019 | |
CZ | 04.12.2019 | ||
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
RO | 04.12.2019 | ||
RS | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
Former [2020/32] | AL | 04.12.2019 | |
FI | 04.12.2019 | ||
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
RS | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
Former [2020/26] | FI | 04.12.2019 | |
HR | 04.12.2019 | ||
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
RS | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
Former [2020/23] | FI | 04.12.2019 | |
LT | 04.12.2019 | ||
LV | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
GR | 05.03.2020 | ||
Former [2020/22] | FI | 04.12.2019 | |
LT | 04.12.2019 | ||
BG | 04.03.2020 | ||
NO | 04.03.2020 | ||
Former [2020/21] | NO | 04.03.2020 | Cited in | International search | [A]WO9849562 (PENTAPHARM AG [CH], et al) [A] 1-19 * page 10, paragraph 5 - page 11, paragraph 1; example 7 *; | [AD]EP0942284 (DADE BEHRING MARBURG GMBH [DE]) [AD] 1-19 * example 1; claims 1-12 *; | [AD]WO2017139567 (INSTR LABORATORY CO [US]) [AD] 1-19 * page 1, line 25 - page 2, line 13; claims 1-20 *; | [A] - ROSSI N A A ET AL, "In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 30, no. 4, doi:10.1016/J.BIOMATERIALS.2008.09.057, ISSN 0142-9612, (20090201), pages 638 - 648, (20081101), XP025693622 [A] 1-19 * paragraph [2.7.] * DOI: http://dx.doi.org/10.1016/j.biomaterials.2008.09.057 | [A] - ZU D. LIU ET AL, "Design of clinically useful iron(III)-selective chelators", MEDICINAL RESEARCH REVIEWS, (20010101), vol. 22, no. 1, doi:10.1002/med.1027, ISSN 0198-6325, pages 26 - 64, XP055210372 [A] 1-19 * table I * * paragraph [4.A.1.] * * paragraph [4.B.2.] * DOI: http://dx.doi.org/10.1002/med.1027 | by applicant | US3522148 | EP0420332 | EP0524803 | EP0585987 | EP0942284 | EP0914118 | US2017234895 |